Simple Sell Setup with a interesting Risk Ratio ( > 1:3 ). Details below or on chart:
FUNDAMENTAL NOTE:
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.
SETUP MODE
---------------------------------------
# ACCOUNT BALANCE: 10K #
---------------------------------------
- SELL AREA: 55.60/55.95
- STOP LOSS: 56.85
- TARGET: 52.00/51.50
=====================
MONEY MANAGEMENT
---------------------------------------
# SELL: 10.000$ (Risk: 3%) #
---------------------------------------
- SIZE: 200 lots/shares
- POTENTIAL LOSS: 300$
- POTENTIAL GAIN: 1.100$
TRADER NOTE:
Minimun Account: 1.000$ (20 lots/shares)
...Thank you for your support and trade with care!
FUNDAMENTAL NOTE:
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.
SETUP MODE
---------------------------------------
# ACCOUNT BALANCE: 10K #
---------------------------------------
- SELL AREA: 55.60/55.95
- STOP LOSS: 56.85
- TARGET: 52.00/51.50
=====================
MONEY MANAGEMENT
---------------------------------------
# SELL: 10.000$ (Risk: 3%) #
---------------------------------------
- SIZE: 200 lots/shares
- POTENTIAL LOSS: 300$
- POTENTIAL GAIN: 1.100$
TRADER NOTE:
Minimun Account: 1.000$ (20 lots/shares)
...Thank you for your support and trade with care!
Note
...pending orderNote
Note
Rebound in play... follow our idea!Trade closed: target reached
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.